According to Santhera Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$56.55 M. In 2023 the company made an earning of $90.55 M an increase over its 2022 earnings that were of -$54.59 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.